Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
MY TRIALS
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Register a trial
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT03151265
Registration number
NCT03151265
Ethics application status
Date submitted
9/05/2017
Date registered
12/05/2017
Titles & IDs
Public title
A Prospective Pilot Study Investigating the Impact of ThermaCare on Flexibility, Muscle Relaxation & Low Back Pain
Query!
Scientific title
A Prospective Open Label Pilot Study Investigating the Impact of ThermaCare on Flexibility, Muscle Relaxation & Low Back Pain in Two Different Populations
Query!
Secondary ID [1]
0
0
2017THERMA
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Low Back Pain
0
0
Query!
Condition category
Condition code
Musculoskeletal
0
0
0
0
Query!
Other muscular and skeletal disorders
Query!
Neurological
0
0
0
0
Query!
Other neurological disorders
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment: Devices - ThermaCare Low Back Heat Wrap
Experimental: Low Back Pain Group - Low Back Pain (LBP) group will be assessed on two consecutive days. The first day will have no ThermaCare intervention applied, and is for a Baseline assessment of flexibility, muscle relaxation and low back pain.
The second day will have the ThermaCare Low Back Heat Wrap intervention applied, and will have the same assessments as the Baseline day.
Experimental: Active in Sport Group - Sport group will be assessed on two consecutive days. The first day will have no ThermaCare intervention applied, and is for a baseline assessment of flexibility, muscle relaxation and low back pain.
The second day will have the ThermaCare Low Back Heat Wrap intervention applied, and will have the same assessments as the Baseline day.
Treatment: Devices: ThermaCare Low Back Heat Wrap
The ThermaCare Low Back Heat Wrap, is a continuous, low-level, direct heat therapy. It comes in the form of a heat-pack that is strapped to the low back. Heat is provided for approximately 8-hours.
Query!
Intervention code [1]
0
0
Treatment: Devices
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Change in Movement Data Over Time
Query!
Assessment method [1]
0
0
Collection of movement data from all participants. The results listed here depict the average change in Trunk Range of Motion (ROM) between day 1 and day 2 PM sessions
Query!
Timepoint [1]
0
0
Change from Baseline movement data after 1 consecutive day.
Query!
Primary outcome [2]
0
0
Change in Erector Spinae Muscle Activity Over Time
Query!
Assessment method [2]
0
0
Collection of erector spinae muscle activity data from all participants. The results provided depict the mean muscle-activity difference between the day 1 and day 2 PM sessions.
Surface Electromyography (sEMG) sensors are adhered utilizing a height-specific sensor placement template. Placement is parallel with the L3 vertebrae.
Evaluated in the form of the flexion-relaxation response. When performing a forward flexion movement, muscle activation occurs at the commencement of the movement (when bending down;concentric), as well as during the return to the upright position (eccentric). At maximum flexion, minimal muscle activation is expected (i.e. muscle relaxation). However, in subjects with Low-back pain, muscle relaxation is often absent.
As such, the following formula is used to evaluate the flexion-relaxation response.
Sum of sEMG activity at maximum flexion divided by the summed sEMG activity of both concentric and eccentric muscle activation.
Query!
Timepoint [2]
0
0
Change from Baseline Erector spinae muscle activity data after 1 consecutive day.
Query!
Secondary outcome [1]
0
0
A Change Over Time in Range of Motion in Any One Plane of Movement Compared to Pre-intervention Range of Motion.
Query!
Assessment method [1]
0
0
Maximal range of low back movement in sagittal,axial and coronal planes. Results depict the change in Pelvis ROM in the sagittal plane.
Query!
Timepoint [1]
0
0
Change from Baseline after 1 consecutive day.
Query!
Secondary outcome [2]
0
0
In Group 1 (LBP Patients), a Change in Maximum Pain During Movement Score, for Any One Plane of Movement.
Query!
Assessment method [2]
0
0
Pain Score out of 10 as rated on the ViMove scale during movement assessment. Score from 0-10 where 10 indicates maximum pain, and 0 indicates no pain. The results depicted indicate the change in pain scores between baseline and post-intervention
Query!
Timepoint [2]
0
0
Change from Baseline after 1 consecutive day.
Query!
Secondary outcome [3]
0
0
A Change in Muscle Activity From Baseline in Subjects Where Abnormal EMG Activity During Baseline is Detected.
Query!
Assessment method [3]
0
0
Surface EMG measurement of erector spinae muscle activity at L3 vertebra level
Query!
Timepoint [3]
0
0
Change from Baseline after 1 consecutive day.
Query!
Secondary outcome [4]
0
0
Change in Pain From Baseline
Query!
Assessment method [4]
0
0
Pain Score out of 10 as measured on a Numeric Rating scale (NRS)
Score from 0-10 where 10 indicates maximum pain, and 0 indicates no pain.
The results depicted indicate the change in NRS scores between baseline and post-intervention
Query!
Timepoint [4]
0
0
Change from Baseline after 1 consecutive day.
Query!
Secondary outcome [5]
0
0
Observation of Self-reported Changes in Functional Status Pre- and Post- ThermaCare Application as Measured by the Oswestry Disability Index (ODI) if Subjects Scored >3 on the NRS
Query!
Assessment method [5]
0
0
Measurement of disability related to low back pain. Contains 10 sections, each of which can be from from 0-5 for a maximum score of 50.
50 indicates maximum possible disability (bed-bound - or are exaggerating their symptoms).
The results depicted indicate the change in NRS scores between baseline and post-intervention
Query!
Timepoint [5]
0
0
Change from Baseline after 1 consecutive day.
Query!
Secondary outcome [6]
0
0
Impression of Change From Subjects Post Intervention and/or Assessment Period Using the Patient Global Impression of Change Scale (PGIC).
Query!
Assessment method [6]
0
0
Measurement of perceived change in Low back pain. Score from a scale of 1-7. 1 indicates no change (or condition has worsened), 7 indicates a considerable improvement.
The results depicted indicate the change in PGIC scores between Day 1 and Day 2 (intervention)
Query!
Timepoint [6]
0
0
Change from Baseline after 1 consecutive day.
Query!
Secondary outcome [7]
0
0
Observation of Self-reported Changes in Functional Status Pre- and Post- ThermaCare Application as Measured by the Roland Morris Disability Questionnaire (RMDQ) if Subjects Scored >3 on the NRS
Query!
Assessment method [7]
0
0
Measurement of disability related to low back pain. A checklist of 24 items. A score of 24 indicates maximum disability.
Query!
Timepoint [7]
0
0
Change from Baseline after 1 consecutive day.
Query!
Eligibility
Key inclusion criteria
Inclusion criteria for recent low back pain patients (Group 1):
1. Adults between the age of 21-54 inclusive, male and female.
2. Low back pain is the primary source of pain over the last 3 weeks.
3. Have experienced and received treatment for muscle related low back pain with an average score of at least 3/10 on a 10-point Numeric Rating scale over the past 3 weeks.
4. Must be able to communicate fluently in English.
5. Must provide written informed consent.
6. Must agree to confidentiality.
Inclusion criteria for people who are active in sports (Group 2):
1. Adults between the age of 21-54 inclusive, male and female.
2. Participate in 30 min of moderate to high intensity exercise 3 times per week. As defined by Borg Rating of Perceived Exertion scale.
3. Must be able to communicate fluently in English.
4. Must provide written informed consent.
5. Must agree to confidentiality.
Query!
Minimum age
21
Years
Query!
Query!
Maximum age
54
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
Exclusion Criteria (applies to both Groups):
1. The subject is pregnant.
2. The subject has a severe hearing impairment.
3. The subject is cognitively impaired.
4. Known allergic skin reaction to tapes and plasters.
5. Co-morbidities of neoplasm, infection, fracture, inflammatory or metabolic disorder that has potential to affect the lumbo-pelvic region.
6. Person who is currently enrolled in another investigational drug or device study.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Non-randomised trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
NA
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
3/07/2017
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
21/12/2017
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
40
Query!
Recruitment in Australia
Recruitment state(s)
VIC
Query!
Recruitment hospital [1]
0
0
Clifton Hill Physiotherapy - Clifton Hill
Query!
Recruitment hospital [2]
0
0
Peak MSK Physiotherapy - Hampton
Query!
Recruitment hospital [3]
0
0
Hoppers Physio - Hoppers Crossing
Query!
Recruitment postcode(s) [1]
0
0
3068 - Clifton Hill
Query!
Recruitment postcode(s) [2]
0
0
3188 - Hampton
Query!
Recruitment postcode(s) [3]
0
0
3168 - Hoppers Crossing
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Query!
Name
dorsaVi Ltd
Query!
Address
Query!
Country
Query!
Other collaborator category [1]
0
0
Other
Query!
Name [1]
0
0
Monash University
Query!
Address [1]
0
0
Query!
Country [1]
0
0
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
The objective of this Investigator Initiated study is to evaluate the effectiveness of ThermaCare HeatWraps in improving flexibility and low back muscle relaxation, and in participants experiencing pain, reducing pain during movement. This study is an intervention trial on two discrete subject samples; (1) people with recent back pain, and (2) people who regularly play sport. ViMove wearable sensors provide precise objective measurements of low back muscle activity and movement in real time and can capture a patient's reporting of pain during movement. Outcomes will be assessed through standard ViMove protocols in conjunction with multiple validated measures of pain, perception of change, and function.
Query!
Trial website
https://clinicaltrials.gov/study/NCT03151265
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Andrew Ronchi, PhD
Query!
Address
0
0
dorsaVi Ltd
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Undecided
Query!
No/undecided IPD sharing reason/comment
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Type
Other Details
Attachment
Informed consent form
https://cdn.clinicaltrials.gov/large-docs/65/NCT03151265/ICF_000.pdf
Study protocol
Study Protocol and Statistical Analysis Plan
https://cdn.clinicaltrials.gov/large-docs/65/NCT03151265/Prot_SAP_001.pdf
Statistical analysis plan
Study Protocol and Statistical Analysis Plan
https://cdn.clinicaltrials.gov/large-docs/65/NCT03151265/Prot_SAP_001.pdf
Results publications and other study-related documents
No documents have been uploaded by study researchers.
Results are available at
https://clinicaltrials.gov/study/NCT03151265